Serefex Announces the TriBan Antimicrobial System
HUDSON, Ohio, March 22, 2011 /PRNewswire/ — Serefex Corporation (Pink Sheets: SFXC) announced today that it has added to its line of “Infection Control and Healthy Building Products” through its master distribution agreement with Rochester, MI based Triton Technology Group. Serefex’s agreement with Triton provides it with product lines of technologically advanced solutions designed to restore and maintain a building’s healthy environment.
Brian Dunn, President and CEO of Serefex said, “The TriBan Antimicrobial System is the next offering in our platform focusing on the interior space of the building. TriBan is a durable, continually active Antimicrobial System designed to reduce the occurrence of and exposure to microbes of all kinds; including pathogenic bacteria (MRSA, VRE & E. Coli), fungi (mold) and yeasts. Thus promoting a safer, healthier environment throughout the entire facility.
TriBan is a powerful non-leaching Technology System whose antimicrobial active components are registered with the U.S. Environmental Protection Agency and comparable regulatory bodies around the world. Once applied, TriBan’s materials will not wash off with cleansers or chemicals, is colorless, odorless, safe to touch and is compatible with virtually all substrates, including natural and synthetic fibers, tile, stone, concrete, and carpeting.”
“As our Health Care Industry continues to face the staggering costs of Hospital Acquired Infections (HAIs) in this country, estimated to reach up to $33.8 billion according to the Centers for Disease Control and Prevention, we are bringing cost effective proven technologies to the marketplace to address these serious problems,” added Mr. Dunn.
For additional information, shareholders are encouraged to e-mail Serefex at email@example.com. They have started an overhaul of their existing website and are looking forward to its re-launch shortly.
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks. You should consider these factors in evaluating the forward-looking statements included herein, and not place under reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Serefex Corporation under takes no obligation to update such statements.
SOURCE Serefex Corporation